Daniel T Eitzman
Professor of Internal Medicine
[email protected]

Available to mentor
Daniel T Eitzman
Professor
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Caswell Diabetes Institute
    • Center Member
      Samuel and Jean Frankel Cardiovascular Center
    Recent Publications See All Publications
    • Journal Article
      Beta1-receptor blockade attenuates atherosclerosis progression following traumatic brain injury in apolipoprotein E deficient mice.
      Wang J, Venugopal J, Silaghi P, Su EJ, Guo C, Lawrence DA, Eitzman DT. PLoS One, 2023 18 (5): e0285499 DOI:10.1371/journal.pone.0285499
      PMID: 37235594
    • Journal Article
      Resolution of Sickle Cell Crisis Following Administration of Amiodarone.
      Silaghi P, Eitzman DT. Eur J Case Rep Intern Med, 2023 10 (6): 003879 DOI:10.12890/2023_003879
      PMID: 37305002
    • Journal Article
      Amiodarone improves anemia in a murine model of sickle cell disease and is associated with increased erythrocyte bis(monoacylglycerol) phosphate.
      Venugopal J, Wang J, Guo C, Eitzman DT. Sci Rep, 2022 Sep 30; 12 (1): 16437 DOI:10.1038/s41598-022-20955-5
      PMID: 36180774
    • Journal Article
      KLF11 Protects against Venous Thrombosis via Suppressing Tissue Factor Expression.
      Liang W, Lu H, Sun J, Zhao G, Wang H, Guo Y, Eitzman D, Chen YE, Fan Y, Zhang J. Thromb Haemost, 2022 May; 122 (5): 777 - 788. DOI:10.1055/s-0041-1735191
      PMID: 34428834
    • Preprint
      Beta-receptor blockade attenuates atherosclerosis progression following traumatic brain injury in apolipoprotein E deficient mice
      Eitzman DT, Venugopal J, Wang J, Su EJ, Guo C, Lawrence DA. Research Square, DOI:10.21203/rs.3.rs-1454771/v1
    • Preprint
      Amiodarone improves anemia in a murine model of sickle cell disease and is associated with increased erythrocyte bis(monoacylglycerol) phosphate
      Venugopal J, Wang J, Guo C, Eitzman DT. Research Square, DOI:10.21203/rs.3.rs-1442536/v1
    • Journal Article
      Interleukin-1 receptor antagonism leads to improved anaemia in a murine model of sickle cell disease and is associated with reduced ex vivo platelet-mediated erythrocyte sickling.
      Venugopal J, Wang J, Guo C, Eitzman DT. Br J Haematol, 2022 Feb; 196 (4): 1040 - 1051. DOI:10.1111/bjh.17941
      PMID: 34786709
    • Journal Article
      Interleukin-1 receptor inhibition reduces stroke size in a murine model of sickle cell disease.
      Venugopal J, Wang J, Mawri J, Guo C, Eitzman D. Haematologica, 2021 Sep 1; 106 (9): 2469 - 2477. DOI:10.3324/haematol.2020.252395
      PMID: 32817286